Acetazolamide is a diuretic medication that treats
hyperkalemic periodic paralysis, or HYPP, in horses. HYPP occurs when
a genetic defect disrupts a protein responsible for opening and closing
a gateway in the membrane of muscle cells. This allows uncontrolled
sodium influxes to take place and alters the voltage current of muscle
cells, resulting in muscle weakness or twitching. High levels of blood
potassium are typically present when the protein disruption occurs.
Acetazolamide belongs to a class of medications called carbonic anhydrase
inhibitors.
Active Ingredients: Acetazolamide 250 mg
Warnings:
Keep this product out of reach of children and animals.
Do not use or store in or near open flame or heat.
Acetazolamide is intended for use in horses, cats,
and dogs only. Not for use in humans.
CAUTION: This medication has the potential
to produce hypokalemia in some animals.
Do not use Acetazolamide in animals with acidemia.
Use cautiously in animals that are sensitive to sulfonamide drugs.
Acetazolamide is not for use in animals with kidney
or liver disease, Addison's disease, lung disease, breathing problems,
or low sodium or potassium levels.
Although side effects in horses are not common, Acetazolamide
may cause numerous side effects in dogs and cats undergoing treatment
for glaucoma. These side effects may include staggering, behavioral
changes, sleepiness, confusion, excitability, confusion, anemia, weakness,
lethargy, pale gum, and bleeding tendencies. Rash, bladder stones, and
changes in urination are also possible.
Consult your veterinarian before beginning treatment
if your animal is taking phenytoin, procainamide, insulin, corticosteroids,
quinidine, amphotericin B, corticotrophin, other diuretics, or digoxin.
Interactions are possible.
Do not use this medication in animals with a known
allergy to it or to similar medications.